MORGAN STANLEY PLC/CALL/AMGEN/260/0.1/20.09.24 Share Price

Warrant

DE000MB0CPR0

Market Closed - Börse Stuttgart 19:20:09 05/07/2024 BST
5.05 EUR +3.27% Intraday chart for MORGAN STANLEY PLC/CALL/AMGEN/260/0.1/20.09.24
Current month-4.90%
1 month+1.20%
Date Price Change
05/07/24 5.05 +3.27%
04/07/24 4.89 -1.21%
03/07/24 4.95 -5.35%
02/07/24 5.23 +0.77%
01/07/24 5.19 -2.26%

Delayed Quote Börse Stuttgart

Last update July 05, 2024 at 07:20 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying AMGEN INC.
Issuer Morgan Stanley
WKN MB0CPR
ISINDE000MB0CPR0
Date issued 09/11/2022
Strike 260 $
Maturity 20/09/2024 (76 Days)
Parity 10 : 1
Emission price 6.91
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 6.73
Lowest since issue 0.83
Delta0.87x
Omega 4.877
Premium1.4x
Gearing5.63x
Moneyness 1.196
Difference Strike -50.88 $
Difference Strike %-19.57%
Spread 0.03
Spread %0.59%
Theoretical value 5.095
Implied Volatility 37.83 %
Total Loss Probability 16.74 %
Intrinsic value 4.693
Present value 0.4015
Break even 315.23 €
Theta-0.05x
Vega0.03x
Rho0.04x

Company Profile

Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other (5.8%): primarily royalties. The United States account for 70.3% of net sales.
Sector
-
More about the company

Ratings for Amgen Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Amgen Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
310.9 USD
Average target price
316.4 USD
Spread / Average Target
+1.79%
Consensus